Providing Medicaid coverage is likely to lead to meaningful health benefits for at least a subset of previously uninsured, low-income Americans, according to a post-hoc analysis of the randomized ...
SALT LAKE CITY, Oct. 30, 2025 – Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced a post-hoc analysis of the Precision Medicine in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results